{"title":"脑胶质瘤的免疫学标志物。","authors":"N De Tribolet","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Immunological markers of human gliomas have been looked for by studying the patient's immune response or by raising heteroantisera against these tumours. More recently, the hybridoma technology has allowed to produce monoclonal antibodies recognizing a single antigenic determinant. This paper describes the production of monoclonal antibodies against human glioma-associated antigens and discusses their possible applications as diagnostic tools.</p>","PeriodicalId":75639,"journal":{"name":"Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften","volume":" ","pages":"113-21"},"PeriodicalIF":0.0000,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Immunological markers of brain gliomas.\",\"authors\":\"N De Tribolet\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Immunological markers of human gliomas have been looked for by studying the patient's immune response or by raising heteroantisera against these tumours. More recently, the hybridoma technology has allowed to produce monoclonal antibodies recognizing a single antigenic determinant. This paper describes the production of monoclonal antibodies against human glioma-associated antigens and discusses their possible applications as diagnostic tools.</p>\",\"PeriodicalId\":75639,\"journal\":{\"name\":\"Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften\",\"volume\":\" \",\"pages\":\"113-21\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1981-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Immunological markers of human gliomas have been looked for by studying the patient's immune response or by raising heteroantisera against these tumours. More recently, the hybridoma technology has allowed to produce monoclonal antibodies recognizing a single antigenic determinant. This paper describes the production of monoclonal antibodies against human glioma-associated antigens and discusses their possible applications as diagnostic tools.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
